Cargando…

Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State

Respiratory syncytial virus infection (RSVI) is an acute medical and social problem in many countries globally. Infection is most dangerous for infants under one year old and the elderly. Despite its epidemiological relevance, only two drugs are registered for clinical use against RSVI: ribavirin (a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shtro, Anna A., Petukhova, Galina D., Romanova, Aleksandra S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000545/ https://www.ncbi.nlm.nih.gov/pubmed/35408661 http://dx.doi.org/10.3390/molecules27072263

Ejemplares similares

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
por: Khomenko, Tatyana M., et al.
Publicado: (2021)

Discovery of N-Containing (-)-Borneol Esters as Respiratory Syncytial Virus Fusion Inhibitors
por: Sokolova, Anastasiya S., et al.
Publicado: (2022)

Current State of Respiratory Syncytial Virus Disease and Management
por: Chatterjee, Archana, et al.
Publicado: (2021)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
por: Biagi, Carlotta, et al.
Publicado: (2020)

Respiratory syncytial virus: current and emerging treatment options
por: Turner, Tiffany L, et al.
Publicado: (2014)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
por: Khomenko, Tatyana M., et al.
Publicado: (2023)

Respiratory Syncytial Virus Infection: Treatments and Clinical Management
por: Malik, Shiza, et al.
Publicado: (2023)

Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
por: Rozenbaum, Mark H., et al.
Publicado: (2023)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Diagnosis of Respiratory Syncytial Virus Infection
por: Popow-Kraupp, Therese, et al.
Publicado: (2011)

The prevention of respiratory syncytial virus infection
por: Bollani, L, et al.
Publicado: (2014)

Respiratory Syncytial Virus Infection and Bronchiolitis
por: Piedimonte, Giovanni, et al.
Publicado: (2014)

Severe Respiratory Syncytial Virus Infection
por: Kashiwagi, Yasuyo, et al.
Publicado: (2019)

Identification and Study of the Action Mechanism of Small Compound That Inhibits Replication of Respiratory Syncytial Virus
por: Shtro, Anna A., et al.
Publicado: (2023)

Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection
por: Kubota, Jun, et al.
Publicado: (2022)

Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017
por: Mollers, Madelief, et al.
Publicado: (2019)

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
por: Broadbent, Lindsay, et al.
Publicado: (2015)

Host Responses to Respiratory Syncytial Virus Infection
por: Agac, Ayse, et al.
Publicado: (2023)

Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus
por: Feng, Ziheng, et al.
Publicado: (2022)

Epidemic dynamics of respiratory syncytial virus in current and future climates
por: Baker, Rachel E., et al.
Publicado: (2019)

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection
por: Pålsson, Sandra Axberg, et al.
Publicado: (2020)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus †
por: Joshi, Sameer, et al.
Publicado: (2018)

Respiratory syncytial virus infection: an innate perspective
por: Johansson, Cecilia
Publicado: (2016)

Animal models of respiratory syncytial virus infection
por: Taylor, Geraldine
Publicado: (2017)

Respiratory Syncytial Virus Infection in Elderly Adults
por: Falsey, Ann R., et al.
Publicado: (2012)

The Changing Landscape of Respiratory Syncytial Virus Infections
por: Bem, Reinout A., et al.
Publicado: (2023)

Respiratory Syncytial Virus and Other Pediatric Respiratory Virus Infections
por: L., G.
Publicado: (1998)

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Respiratory Syncytial Virus Seasonality — United States, 2014–2017
por: Rose, Erica Billig, et al.
Publicado: (2018)

Seasonality of Respiratory Syncytial Virus — United States, 2017–2023
por: Hamid, Sarah, et al.
Publicado: (2023)

Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
por: Altamirano-Lagos, María José, et al.
Publicado: (2019)

Late therapeutic intervention with a respiratory syncytial virus L‐protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium
por: Brookes, Daniel W, et al.
Publicado: (2018)

Severe Respiratory Syncytial Virus Bronchiolitis in Infants Is Associated with Reduced Airway Interferon Gamma and Substance P
por: Semple, Malcolm G., et al.
Publicado: (2007)

Functional Features of the Respiratory Syncytial Virus G Protein
por: Anderson, Larry J., et al.
Publicado: (2021)

Bioconjugated nanoparticle detection of respiratory syncytial virus infection
por: Tripp, Ralph A, et al.
Publicado: (2007)

Epidemiology of Respiratory Syncytial Virus Infection in Preterm Infants
por: Resch, Bernhard, et al.
Publicado: (2011)

Respiratory Syncytial Virus Infection in High-Risk Infants
por: Resch, Bernhard
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_prn2qg8dq6degido2jermds1kh